Abnormal regulation of AMPK has been reported in several neurodegenerative diseases, including Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). Here, PRKAA2 is linked to early-onset autosomal dominant Alzheimer disease.